Last reviewed · How we verify
NCT06956066: SHOTBLOCKER
The Effect of SHOTBLOCKER
NA trial testing shotblocker in Shotblocker in 80 participants. Completed in 21 December 2024.
23 November 2024
Quick facts
| Lead sponsor | Istanbul Medeniyet University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | factorial |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 80 |
| Start date | 21 December 2023 |
| Primary completion | 23 November 2024 |
| Estimated completion | 21 December 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- shotblocker — full drug profile →
Conditions studied
- Shotblocker — all drugs for Shotblocker →
- Injection Pain Prevention — all drugs for Injection Pain Prevention →
- Pain — all drugs for Pain →
- Anxiety — all drugs for Anxiety →
Sponsor
Istanbul Medeniyet University
Who can join
18 and older, any sex, with Shotblocker or Injection Pain Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was conducted as a randomized controlled experimental cross over study to examine the effect of injection pain, anxiety and comfort level with the use of Shotblocker in geriatric patients undergoing subcutaneous injection. The study was defined on 80 patients who were inpatients in the internal wards of a hospital, and the experimental and control groups, which provided the appropriate conditions for the study, included the same people. Ethics committee approval, institutional permission and written informed consent forms were obtained from the individuals. Data were obtained by the researcher using Personal Information Form, Visual Analog Scale (VAS), State and Trait Anxiety Scale, Comfort Scale, Visual Patient Satisfaction Scale and Shotblocker.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06956066
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of shotblocker
Trials testing the same drug.
- NCT06381804 — Effect of Shotblocker and Palm Stimulator · NA · completed
- NCT05598372 — Infant Pain During Vaccination and Maternal Anxiety · NA · completed
- NCT06563648 — The Effect of Local Cold Application and ShotBlocker Use in Subcutaneous Injection on Injection Pain and Patient Satisfa · NA · completed
- NCT05246787 — Shotblocker and Breastfeeding on Pain/Comfort During Heel Lance · NA · completed
Other Istanbul Medeniyet University trials
Trials by the same sponsor.
- NCT07478380 — Transcutaneous pO₂ Monitoring in PICU · recruiting
- NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co · recruiting
- NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T · NA · not yet recruiting
- NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care · completed
- NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06956066 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
- Last refreshed: 2 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06956066.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing